Related Experiment Video
Updated: Feb 3, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
Published on: July 30, 2020
Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival
Matthew G Oser1,2,3, Raquel Fonseca1, Abhishek A Chakraborty1,3
1Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Abstract:
Small cell lung cancer (SCLC) accounts for 15% of lung cancers and is almost always linked to inactivating RB1 and TP53 mutations. SCLC frequently responds, albeit briefly, to chemotherapy. The canonical function of the RB1 gene product RB1 is to repress the E2F transcription factor family. RB1 also plays both E2F-dependent and E2F-independent mitotic roles. We performed a synthetic lethal CRISPR/Cas9 screen in an RB1 -/- SCLC cell line that conditionally expresses RB1 to identify dependencies that are caused by RB1 loss and discovered that RB1 -/- SCLC cell lines are hyperdependent on multiple proteins linked to chromosomal segregation, including Aurora B kinase. Moreover, we show that an Aurora B kinase inhibitor is efficacious in multiple preclinical SCLC models at concentrations that are well tolerated in mice. These results suggest that RB1 loss is a predictive biomarker for sensitivity to Aurora B kinase inhibitors in SCLC and perhaps other RB1 -/- cancers. SIGNIFICANCE: SCLC is rarely associated with actionable protooncogene mutations. We did a CRISPR/Cas9-based screen that showed that RB1 -/- SCLC are hyperdependent on AURKB, likely because both genes control mitotic fidelity, and confirmed that Aurora B kinase inhibitors are efficacious against RB1 -/- SCLC tumors in mice at nontoxic doses.See related commentary by Dick and Li, p. 169.This article is highlighted in the In This Issue feature, p. 151.
Insights
Small cell lung cancer cells lacking RB1 show a dependency on Aurora B kinase. Inhibiting this kinase effectively treats RB1-deficient SCLC models, suggesting RB1 loss as a predictive biomarker for Aurora B kinase inhibitors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Small cell lung cancer (SCLC) comprises 15% of lung cancer cases.
- SCLC is strongly associated with inactivating mutations in RB1 and TP53 tumor suppressor genes.
- While chemotherapy offers brief responses, SCLC rarely harbors actionable proto-oncogene mutations.
Purpose of the Study:
- To identify genetic dependencies arising from RB1 loss in SCLC.
- To explore therapeutic strategies targeting RB1-deficient SCLC.
- To evaluate Aurora B kinase as a potential therapeutic target in SCLC.
Main Methods:
- Conducted a synthetic lethal CRISPR/Cas9 screen in an RB1-deficient SCLC cell line.
- Utilized RB1-conditional SCLC cell lines for screening.
- Tested Aurora B kinase inhibitors in preclinical SCLC models.
Main Results:
- RB1-deficient SCLC cell lines exhibit hyperdependence on chromosomal segregation proteins, including Aurora B kinase (AURKB).
- Aurora B kinase inhibition demonstrated efficacy in multiple preclinical SCLC models.
- Inhibitor concentrations were well-tolerated in mouse models.
Conclusions:
- RB1 loss is a potential predictive biomarker for sensitivity to Aurora B kinase inhibitors in SCLC.
- Targeting Aurora B kinase presents a promising therapeutic avenue for RB1-wildtype SCLC.
- This study highlights a novel therapeutic vulnerability in RB1-deficient cancers.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
13:22Genetic Screen for Identification of Multicopy Suppressors in Schizosaccharomyces pombe
Published on: September 13, 2022
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Cell Specific Gene Expression